ReviewMolecules (Basel, Switzerland)2021
Using Micropropagation to Develop Medicinal Plants into Crops.
Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 63 citations in OpenAlex.
- Review
- In Vitro Culture, Genetic Uniformity Assessment, and Biochemical Traits ofPlants (Basel, Switzerland) · 2026Article
- Synergistic effects of plant growth regulators, riboflavin, and iron nanoparticles on secondary metabolites in micropropagated Ceratonia siliqua L.Scientific reports · 2026Article
- An efficient regeneration protocol through somatic embryogenesis and organogenesis for cassava (Plant biotechnology (Tokyo, Japan) · 2025Article
- Stress-Induced Secondary Metabolite Profiling inInternational journal of molecular sciences · 2025Article
- Somatic Mutation Accumulations in Micropropagated Cannabis Are Proportional to the Number of Subcultures.Plants (Basel, Switzerland) · 2024Article
- Properties and Fungal Communities of Different Soils for Growth of the Medicinal Asian Water Plantain,Journal of fungi (Basel, Switzerland) · 2024Article
- Biotechnological approaches for in vitro propagation, conservation and secondary metabolites production in3 Biotech · 2023Review
- A First Approach for the Micropropagation of the Edible and Medicinal HalophytePlants (Basel, Switzerland) · 2023Article
- Review
- Efficient Plant Regeneration System from Leaf Explant Cultures ofPlants (Basel, Switzerland) · 2023Article
- Editorial: Harnessing the sustainable valorization and exploitation of salt tolerant plants.Frontiers in plant science · 2023Article
- Article
- A first approach for the micropropagation of the medicinal halophyteFrontiers in plant science · 2022Article
- New Insights Into Tissue Culture Plant-Regeneration Mechanisms.Frontiers in plant science · 2022Review
- Special Issue: "James D. McChesney, Vision, Passion and Leadership in the Development of Plant-Derived Natural Products".Molecules (Basel, Switzerland) · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medicinal plants are still the major source of therapies for several illnesses and only part of the herbal products originates from cultivated biomass. Wild harvests represent the major supply for therapies, and such practices threaten species diversity as well as the quality and safety of the final products. This work intends to show the relevance of developing medicinal plants into crops and the use of micropropagation as technique to mass produce high-demand biomass, thus solving the supply issues of therapeutic natural substances. Herein, the review includes examples of in vitro procedures and their role in the crop development of pharmaceuticals, phytomedicinals, and functional foods. Additionally, it describes the production of high-yielding genotypes, uniform clones from highly heterozygous plants, and the identification of elite phenotypes using bioassays as a selection tool. Finally, we explore the significance of micropropagation techniques for the following: a) pharmaceutical crops for production of small therapeutic molecules (STM), b) phytomedicinal crops for production of standardized therapeutic natural products, and c) the micropropagation of plants for the production of large therapeutic molecules (LTM) including fructooligosaccharides classified as prebiotic and functional food crops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.